246 related articles for article (PubMed ID: 32250307)
1. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
[TBL] [Abstract][Full Text] [Related]
2. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
3. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D
J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
5. Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.
Gabriel AJ; Almeida MR; Ribeiro MH; Carneiro D; Valério D; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
J Alzheimers Dis; 2018; 61(3):1097-1105. PubMed ID: 29254094
[TBL] [Abstract][Full Text] [Related]
6. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
Chen XR; Shao Y; Sadowski MJ;
J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
[TBL] [Abstract][Full Text] [Related]
7. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
8. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK
Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
[TBL] [Abstract][Full Text] [Related]
10. Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.
Sokolow S; Li X; Chen L; Taylor KD; Rotter JI; Rissman RA; Aisen PS; Apostolova LG
J Alzheimers Dis; 2017; 56(1):229-237. PubMed ID: 27911294
[TBL] [Abstract][Full Text] [Related]
11. APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease: A Longitudinal Study.
Camarda C; Torelli P; Pipia C; Sottile G; Cilluffo G; Camarda R
Curr Alzheimer Res; 2020; 17(8):766-780. PubMed ID: 33167837
[TBL] [Abstract][Full Text] [Related]
12. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.
Lehmann DJ; Johnston C; Smith AD
Hum Mol Genet; 1997 Oct; 6(11):1933-6. PubMed ID: 9302273
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
14. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
15. The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.
Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Viadero C; Peña N
Acta Neurol Scand; 2000 Dec; 102(6):350-3. PubMed ID: 11125748
[TBL] [Abstract][Full Text] [Related]
16. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.
Khan W; Giampietro V; Banaschewski T; Barker GJ; Bokde AL; Büchel C; Conrod P; Flor H; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Lemaître H; Nees F; Paus T; Pausova Z; Rietschel M; Smolka MN; Ströhle A; Gallinat J; Vellas B; Soininen H; Kloszewska I; Tsolaki M; Mecocci P; Spenger C; Villemagne VL; Masters CL; Muehlboeck JS; Bäckman L; Fratiglioni L; Kalpouzos G; Wahlund LO; Schumann G; Lovestone S; Williams SC; Westman E; Simmons A; ; ;
J Alzheimers Dis; 2017; 56(3):1159-1174. PubMed ID: 28157104
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal analysis of
Fokuoh E; Xiao D; Fang W; Liu Y; Lu Y; Wang K
J Genet; 2021; 100():. PubMed ID: 34470924
[TBL] [Abstract][Full Text] [Related]
18. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
19. Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease.
Yamamoto Y; Yasuda M; Mori E; Maeda K
J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):94-6. PubMed ID: 10369830
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.
Wiebusch H; Poirier J; Sévigny P; Schappert K
Hum Genet; 1999 Feb; 104(2):158-63. PubMed ID: 10190327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
